Digital Content 
NEWS #PharmaBuzz
18 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/18/3027680/0/en/Arch-Biopartners-Announces-Health-Canada-No-Objection-Letter-NOL-Granted-for-Investigator-Led-Phase-II-PONTiAK-Trial-Using-Cilastatin-to-Target-Drug-Toxin-Related-Acute-Kidney-Inju.html
02 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/02/2923541/0/en/Arch-Biopartners-Cilastatin-Drug-Candidate-to-Participate-in-the-PONTIAC-Phase-II-Trial-Targeting-Acute-Kidney-Injury-Caused-by-Drug-Toxins.html
27 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/27/2835883/0/en/Arch-Biopartners-Has-Pre-IND-Meeting-With-FDA-to-Discuss-Repurposing-Cilastatin-as-a-New-Treatment-to-Prevent-Acute-Kidney-Injury.html
17 May 2023
// Zachary Brennan ENDPTS
https://endpts.com/merck-defends-antibiotics-approval-from-2019-as-bmj-investigation-points-to-decline-in-fda-standards/
22 Feb 2023
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
25 Mar 2022
// F. Kansteiner FIERCEPHARMA
https://www.fiercepharma.com/pharma/merck-telegraphs-closure-pa-antibiotics-plant-employs-300
Share 